Literature DB >> 3359588

Outpatient closure of the patent ductus arteriosus.

D L Wessel1, J F Keane, I Parness, J E Lock.   

Abstract

We have modified and applied to selected outpatients the transvenous approach to correction of patent ductus arteriosus (PDA) with the Rashkind PDA Occluder. Modifications included establishing the diagnosis and PDA anatomy before catheterization with echocardiography. The sedation/anesthetic regimen was altered to meet the needs with respect to transcatheter PDA closure rather than diagnostic cardiac catheterization. Anticoagulation was avoided. A strategy for management of pin entrapment in the foam was devised. Residual trans-PDA flow after umbrella placement was temporarily occluded with balloon-tipped catheters. These modifications were used in 23 consecutive patients with uncomplicated PDA. Closure was successful in each child. Nineteen of 23 patients were discharged on the day of the procedure. No serious complications were encountered.

Entities:  

Mesh:

Year:  1988        PMID: 3359588     DOI: 10.1161/01.cir.77.5.1068

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Factors influencing the persistence of shunting within 24 hours of catheter occlusion of the ductus arteriosus.

Authors:  R Vitiello; L Benson; N Musewe; R Freedom
Journal:  Br Heart J       Date:  1991-04

Review 2.  Transcatheter occlusion of cardiac septal defects.

Authors:  P S Rao
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

3.  Wire trapping in Rashkind's patent ductus arteriosus occluder: its etiology and how it may be avoided.

Authors:  P G Bjørnstad
Journal:  Cardiovasc Intervent Radiol       Date:  1995 May-Jun       Impact factor: 2.740

4.  Protrusion of the device: a complication of catheter closure of patent ductus arteriosus.

Authors:  J Ottenkamp; J Hess; M D Talsma; T N Buis-Liem
Journal:  Br Heart J       Date:  1992-09

Review 5.  Paediatric cardiac catheterization: innovations.

Authors:  J J Javorski; D D Hansen; P C Laussen; M L Fox; J Lavoie; F A Burrows
Journal:  Can J Anaesth       Date:  1995-04       Impact factor: 5.063

6.  The use of anticoagulation in pediatric cardiac disease.

Authors:  J R Boris; M A Harris
Journal:  Images Paediatr Cardiol       Date:  2003-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.